Drugs / MF59-eH1N1
MF59-eH1N1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00972816 | Sep → Nov 2009 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59-eH1N1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00972816 ↗ |
| Known as | A/H1N1-SOIV | “MF59-eH1N1 vaccine is the same vaccine as A/H1N1-SOIV (Swine Origin A/H1N1 Influenza Virus).” NCT00972816 ↗ |
| Known as | Swine Origin A/H1N1 Influenza Virus | “MF59-eH1N1 vaccine is the same vaccine as A/H1N1-SOIV (Swine Origin A/H1N1 Influenza Virus).” NCT00972816 ↗ |
| Modality | Vaccine | “MF59-eH1N1 vaccine” NCT00972816 ↗ |